Pitfalls of polymyxin antimicrobial susceptibilty testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients

Journal of Antimicrobial Chemotherapy

Volumn 54, Issue 6, 2004, Pages 1057-1061

  Hogardt, Michael ^a   Schmoldt, Sabine ^a   Götzfried, Monika ^a   Adler, Kristin ^a   Heesemann, Jürgen ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Interpretative criteria; Polymyxin resistance; Susceptibility testing methodology

Indexed keywords

COLISTIN; POLYMYXIN; POLYMYXIN B;

ACHROMOBACTER XYLOSOXIDANS; AGAR GEL DIFFUSION; ANALYTIC METHOD; ANALYTICAL ERROR; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; CORRELATION ANALYSIS; COST EFFECTIVENESS ANALYSIS; CYSTIC FIBROSIS; DIAGNOSTIC ACCURACY; DILUTION; DRUG ACTIVITY; FRANCE; GERMANY; INCUBATION TIME; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; REFERENCE VALUE; RELIABILITY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STENOTROPHOMONAS MALTOPHILIA; UNITED KINGDOM; VALIDATION PROCESS;

ACHROMOBACTER DENITRIFICANS; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; COLISTIN; CYSTIC FIBROSIS; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; POLYMYXINS; PSEUDOMONAS AERUGINOSA; QUALITY CONTROL; STENOTROPHOMONAS MALTOPHILIA;

EID: 12344326763     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh470     Document Type: Article

References (10)

1. Evans, M. E., Feola, J. F. & Rapp, R. P. (1999). Polymyxin sulfate and colisin: old antibiotics for emerging multiresistant gram-negative bacteria. Annals of Pharmacotherapy 33, 960-7.
2. Ledson, M. J., Gallagher, M. J., Cowperthwaite, C. et al. (1998). Four years' experience of intravenous colomycin in an adult cystic fibrosis unit. European Respiratory Journal 12, 592-4.
3. Bosso, J. A., Liptak, C. A., Seilheimer, D. K. et al. (1991). Toxicity of colistin in cystic fibrosis patients. Annals of Pharmacotherapy 25, 1168-70.
4. Matsen, J. M., Koepcke, M. J. & Quie, P. G. (1969). Evaluation of the Bauer-Kirby-Sherris-Turck single-disc diffusion method of antibiotic susceptibility testing. Antimicrobial Agents and Chemotherapy 9, 445-53.
5. Pitt, T. L., Sparrow, M., Warner, M. et al. (2003). Survey of resistance of Pseudomonas aeruginosa from UK patients with cystic fibrosis to six commonly prescribed antimicrobial agents. Thorax 58, 794-6.
6. Schulin, T. (2002). In vitro activity of the aerosolized agents colistin and tobramycin and five intravenous agents against Pseudomonas aeruginosa isolated from cystic fibrosis patients in southwestern Germany. Journal of Antimicrobial Chemotherapy 49, 403-6.
7. Li, J., Coulthard, K., Milne, R. et al. (2003). Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis. Journal of Antimicrobial Chemotherapy 52, 987-92.
8. Li, J., Turnidge, J., Milne, R. et al. (2001). In vitro pharmacodynamic properties of colistin and colistin methane-sulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrobial Agents and Chemotherapy 45, 781-5.
9. National Committee for Clinical Laboratory Standards. (2004). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically - Sixth Edition: Approved Standard M7-A6. NCCLS, Villanova, PA, USA.
10. Littlewood, J. M., Koch, C., Lambert, P. A. et al. (2000). A ten year review of colomycin. Respiratory Medicine 94 632-40.